Arkolith/Insider Trading/BLAC/Form 4

Bellevue Global Life Science Investors LLC

10% OwnerBellevue Life Sciences Acquisition Corp. (BLAC) · full profile →Form 4 · filed Feb 16, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
8 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2023Other(J)20K—$01.7M
Feb 14, 2023Other(J)20K—$01.7M
Feb 14, 2023Other(J)20K—$01.7M
Feb 14, 2023Grant(A)430K$10.00$4.3M1.8M
Feb 14, 2023Other(J)20K—$01.6M
Feb 14, 2023Other(J)225K—$01.4M
Feb 14, 2023Other(J)30K—$01.4M
Feb 14, 2023Other(J)20K—$01.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 14, 2023Buy(P)430K$10.00$4.3M430K
Feb 14, 2023Other(J)20K—$0390K
Feb 14, 2023Other(J)20K—$0410K

Transaction Codes

J
Other acquisition / disposition
A
Grant / award
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-005297) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML